Canada - Engels - Health Canada

mylan pharmaceuticals ulc - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - corticosteroids

Verenigde Staten - Engels - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older. important limitations of use: - qvar redihaler is not indicated for the relief of acute bronchospasm. qvar redihaler is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . qvar redihaler is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics

Verenigde Staten - Engels - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

Verenigde Staten - Engels - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

Verenigde Staten - Engels - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

germax sdn. bhd. - beclomethasone dipropionate -

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glenmark pharmaceuticals (malaysia) sdn. bhd. - beclomethasone dipropionate; salbutamol sulphate -

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - beclomethasone dipropionate -

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

orient europharma (m) sdn bhd - beclomethasone dipropionate; formoterol fumarate -

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

cipla malaysia sdn bhd - beclomethasone dipropionate -